International Epilepsy Journal

International Epilepsy Journal

International Epilepsy Journal – Aim And Scope

Open Access & Peer-Reviewed

Submit Manuscript

Aims & Scope

International Epilepsy Journal (IEJ) publishes rigorous, multidisciplinary research advancing the understanding, diagnosis, and treatment of epilepsy and seizure disorders across the lifespan. We prioritize mechanistic studies, clinical innovations, and translational research that bridges neuroscience, genetics, and clinical practice.

Seizure Mechanisms Epilepsy Genetics Antiseizure Therapies Neurophysiology Epilepsy Surgery AI in Epilepsy
⚠ Scope Boundary: We do NOT consider submissions on general neurological conditions unrelated to epilepsy or seizure disorders (e.g., primary neurodegenerative diseases, chronic pain syndromes, rheumatological disorders without epileptic comorbidity).

Research Domains

Tier 1: Core Focus

Seizure Pathophysiology & Mechanisms

Fundamental research on the neurobiological basis of epilepsy and seizure generation.

  • Neuronal excitability and synaptic transmission in epilepsy
  • Ion channel dysfunction and channelopathies
  • Network dynamics and seizure propagation
  • Epileptogenesis and acquired epilepsy models
  • Neurotransmitter systems in seizure control
  • Inflammatory mechanisms in epilepsy
Typical Fit: "Optogenetic dissection of hippocampal interneuron subtypes in temporal lobe epilepsy models" or "Role of GABA receptor subunit composition in pharmacoresistant seizures"
Tier 1: Core Focus

Epilepsy Genetics & Molecular Biology

Genetic architecture, molecular pathways, and precision medicine approaches in epilepsy.

  • Monogenic and polygenic epilepsy syndromes
  • Somatic mosaicism in focal epilepsies
  • Gene-environment interactions in epileptogenesis
  • Functional validation of epilepsy-associated variants
  • Epigenetic regulation in seizure susceptibility
  • Pharmacogenomics of antiseizure medications
Typical Fit: "Whole-exome sequencing identifies novel SCN1A variants in Dravet syndrome cohort" or "CRISPR-based correction of KCNQ2 mutations in patient-derived neurons"
Tier 1: Core Focus

Clinical Epileptology & Diagnostics

Advances in clinical assessment, diagnostic technologies, and seizure classification.

  • EEG biomarkers and advanced neurophysiology
  • Neuroimaging in epilepsy (MRI, PET, MEG)
  • Seizure semiology and syndrome classification
  • Differential diagnosis of paroxysmal events
  • Epilepsy monitoring and wearable technologies
  • Cognitive and neuropsychological assessment
Typical Fit: "Machine learning classification of interictal epileptiform discharges in pediatric EEG" or "7T MRI detection of focal cortical dysplasia in MRI-negative epilepsy"
Tier 1: Core Focus

Epilepsy Therapeutics & Management

Pharmacological, surgical, and neuromodulation approaches to seizure control.

  • Novel antiseizure medication development and trials
  • Drug-resistant epilepsy mechanisms and management
  • Epilepsy surgery outcomes and techniques
  • Neuromodulation (VNS, RNS, DBS) for epilepsy
  • Dietary therapies (ketogenic diet, modified Atkins)
  • Precision medicine and treatment optimization
Typical Fit: "Phase II trial of cannabidiol in Lennox-Gastaut syndrome" or "Predictors of seizure freedom following laser interstitial thermal therapy for mesial temporal sclerosis"
Tier 2: Secondary Focus

Comorbidities & Quality of Life

Psychiatric, cognitive, and psychosocial aspects of living with epilepsy.

  • Depression, anxiety, and psychiatric comorbidities
  • Cognitive impairment and memory dysfunction
  • Sleep disorders in epilepsy
  • Quality of life assessment and interventions
  • Social stigma and patient advocacy
  • Transition of care from pediatric to adult services
Tier 2: Secondary Focus

Special Populations & Syndromes

Age-specific and syndrome-specific epilepsy research.

  • Neonatal and infantile epilepsy syndromes
  • Childhood epilepsy with centrotemporal spikes (Rolandic epilepsy)
  • Juvenile myoclonic epilepsy and adolescent-onset syndromes
  • Epilepsy in pregnancy and women's health
  • Elderly-onset epilepsy and aging
  • Epilepsy in intellectual disability and autism spectrum disorder
Tier 2: Secondary Focus

Acute Symptomatic Seizures

Seizures occurring in the context of acute brain insults (epilepsy-related).

  • Post-traumatic epilepsy and traumatic brain injury
  • Seizures following stroke (early and late onset)
  • Infectious causes: encephalitis, meningitis, neurocysticercosis
  • Autoimmune encephalitis with seizures
  • Status epilepticus management and outcomes
  • Seizure prophylaxis in neurocritical care
Tier 3: Emerging Areas

Technology & Innovation

Cutting-edge technologies transforming epilepsy research and care (selective consideration).

  • Artificial intelligence for seizure prediction and detection
  • Machine learning in EEG analysis and diagnosis
  • Closed-loop neuromodulation systems
  • Digital health and telemedicine in epilepsy
  • Biomarker discovery using multi-omics approaches
  • Brain-computer interfaces for seizure control
Note: Emerging area submissions undergo additional editorial review to ensure direct relevance to epilepsy research and clinical practice. Pure technology papers without clear epilepsy application are out of scope.

Explicitly Out of Scope

To maintain focus and editorial efficiency, IEJ does NOT consider submissions in the following areas unless they demonstrate direct, mechanistic relevance to epilepsy or seizure disorders:

Primary Neurodegenerative Diseases

Alzheimer's disease, Parkinson's disease, dementia, or other neurodegenerative disorders without established epileptic comorbidity or seizure phenotype.

Chronic Pain Syndromes

Back pain, chronic pain, neuropathy, fibromyalgia, or pain management studies unrelated to epilepsy treatment side effects or comorbidities.

Rheumatological & Autoimmune Disorders

Lupus, rheumatoid arthritis, osteoarthritis, psoriatic arthritis, reactive arthritis, septic arthritis, spondyloarthritis, Raynaud's phenomenon, or osteoporosis unless directly linked to epilepsy pathophysiology.

General Neurological Conditions

Multiple sclerosis, Lyme disease, spinal cord injury, spinal stenosis, or cerebral palsy as primary focus, unless seizures are a central research question.

Primary Headache Disorders

Migraine, tension headache, or cluster headache studies without clear epilepsy overlap (e.g., migraine-epilepsy comorbidity mechanisms may be considered).

General Cognitive Science

Broad cognitive science, clinical neuropsychology, or neuroscience research without specific application to epilepsy-related cognitive dysfunction.

Article Types & Editorial Priorities

Priority 1: Fast-Track

Expedited Review

  • Original Research Articles (mechanistic, clinical trials)
  • Systematic Reviews & Meta-Analyses
  • Methods & Resources (novel techniques, datasets)
  • Translational Research (bench-to-bedside)
Priority 2: Standard Review

Regular Processing

  • Short Communications (preliminary findings)
  • Data Notes (negative results, replication studies)
  • Perspectives & Commentaries (invited or unsolicited)
  • Clinical Practice Guidelines
  • Educational Reviews
Rarely Considered

Selective Acceptance

  • Case Reports (only if exceptionally novel syndrome or mechanism)
  • Opinion Pieces (by invitation only)
  • Conference Abstracts (special issues only)
  • Letters to the Editor (response to published articles)
Preprint Policy: IEJ welcomes submissions previously posted on recognized preprint servers (bioRxiv, medRxiv). Authors must disclose preprint DOI at submission and update preprint with publication details upon acceptance.

Editorial Standards & Requirements

Reporting Guidelines

  • Clinical Trials: CONSORT statement compliance required
  • Observational Studies: STROBE checklist mandatory
  • Systematic Reviews: PRISMA guidelines adherence
  • Animal Research: ARRIVE guidelines 2.0 compliance
  • Diagnostic Studies: STARD reporting standards
  • Case Reports: CARE guidelines (when accepted)

Data & Ethics Policies

  • Data Sharing: Raw data deposition in public repositories encouraged
  • Clinical Trial Registration: Prospective registration required (ClinicalTrials.gov, EudraCT)
  • Ethics Approval: IRB/ethics committee approval mandatory for human studies
  • Informed Consent: Documentation required for all human participants
  • Animal Welfare: IACUC approval and humane endpoints required
  • Conflict of Interest: Full disclosure using ICMJE forms

Editorial Performance Metrics

21 days
Median Time to First Decision
28%
Acceptance Rate (2023)
45 days
Acceptance to Online Publication
Open
Article Processing Charges (APC) Available
Questions About Scope? If you are uncertain whether your manuscript fits within IEJ's scope, we encourage pre-submission inquiries. Contact the editorial office with a 250-word abstract and brief rationale for fit. We aim to respond within 5 business days to help you make an informed submission decision.